Search
Adaptive Biotechnologies Corp
ADPTAdd to Watchlist
27.980USD
+1.150+4.29%
Close 11-06 16:00（ET）
4.47BMarket Cap
LossP/E TTM
After-hours 17:18 (ET)27.510USD-0.490-1.75%
After-hours 17:18 (ET)Adaptive Biotechnologies Corp (ADPT) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Adaptive Biotechnologies Corp in the past month.
Buy
3 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
29.813USD+11.91%
ADPT Analyst Recommendation Trends
In the current month, ADPT has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ADPT average Analyst price target in the last month is 29.813.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
3
3
3
3
3
5
4
4
4
4
4
4
4
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
8
8
8
8
8
8
8
ADPT Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, ADPT EPS is projected to reach -0.068 in FY2026Q4, following reported EPS of 0.018 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.16
-0.13
-0.10
-0.07
-0.09
Actual
-0.13
-0.25
0.02
--
--
Surprise
+19.49%
-86.09%
+118.76%
--
--
FAQs
What is Adaptive Biotechnologies Corp's expected revenue for the next quarter?
Adaptive Biotechnologies Corp's expected revenue is 79.51M.
What is Adaptive Biotechnologies Corp's price target?
Analysts forecast that Adaptive Biotechnologies Corp's price target is USD 29.81, with the highest forecast at USD 35.00 and the lowest forecast at USD 21.00.
How have Adaptive Biotechnologies CorpADPT's recent earnings per share performed?
The market expectation was USD 0.02, while Adaptive Biotechnologies CorpADPT's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Adaptive Biotechnologies Corp?
Based on the ratings of Adaptive Biotechnologies Corp's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.